🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT06599086
Recruiting Not applicable

Efficacy of Steroid Injection in Patients With Bifid Median Nerve Diagnosed Carpal Tunnel Syndrome

NCT06599086 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-09-15
Last updated
2025-05-30

Condition(s) studied

Carpal Tunnel Syndrome

Investigational drug(s) / intervention(s)

2 cc:(1 cc betamethasone dipropionate+1cc physiological saline)

2 cc:(1 cc betamethasone dipropionate+1cc physiological saline): Each patient will receive 2 cc:(1 cc betamethasone dipropionate+1cc physiological saline) perineural injection into the median nerve under US guidance, for 1 session.

Study summary

Various median nerve anatomical variations have been reported in the literature.One of these is the bifid median nerve.Due to its relatively higher cross-sectional area, it can facilitate compression of the median nerve in the carpal tunnel.Therefore, bifid median nerve is relatively common in patients with CTS.Some studies have shown that the bifid median nerve has an effect on surgical failure in the treatment of carpal tunnel syndrome.Apart from surgical treatment, perineural injection with corticosteroids is a treatment method that has been used for a long time in the treatment of mild and moderate carpal tunnel syndrome.It is controversial whether bifid median nerve has a negative effect on treatment effectiveness.When looking at the literature, there is no previous study on this subject.With the introduction of ultrasound into our daily practice, the frequency of ultrasound-guided perineural injections has increased.Ultrasound allowed us to see variations in the median nerve before injection.The aim of the study is to compare the effectiveness of steroid injection in patients with CTS with bifid median nerve and patients with CTS with non-variant median nerve.It is also to investigate whether this anatomical variation has a negative effect on the treatment.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being between the ages of 18-65 * Being clinically diagnosed with Carpal Tunnel Syndrome * Confirmation of mild and moderate Carpal Tunnel Syndrome diagnosis with EMG * Diagnosis of bifid median nerve after ultrasound evaluation, No variation was detected for the control group either. * Having typical Carpal Tunnel Syndrome symptoms for at least 3 months Exclusion Criteria: * History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome, or wrist surgery * History of Inflammatory arthritis, hypothyroidism, pregnancy,rheumatological disorders or heart battery * current warfarin use, Prior steroid injection for CTS, trauma or neoplasm at the injection site, hypersensitivity to corticosteroids or skin infection at the injection site * other median nerve variations and presence of persistent median artery.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Etlik City Hospital Ankara Ankara Recruiting

More Yunus Burak Bayır trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06599086 on ClinicalTrials.gov ↗ ← All trials in Turkey